Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Current Gastroenterology Reports
Erschienen in:

27.02.2024

Artificial Intelligence and IBD: Where are We Now and Where Will We Be in the Future?

verfasst von: Mehwish Ahmed, Molly L. Stone, Ryan W. Stidham

Erschienen in: Current Gastroenterology Reports | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Artificial intelligence (AI) is quickly demonstrating the ability to address problems and challenges in the care of IBD. This review with commentary will highlight today’s advancements in AI applications for IBD in image analysis, understanding text, and replicating clinical knowledge and experience.

Recent Findings

Advancements in machine learning methods, availability of high-performance computing, and increasing digitization of medical data are providing opportunities for AI to assist in IBD care. Multiple groups have demonstrated the ability of AI to replicate expert endoscopic scoring in IBD, with expansion into automated capsule endoscopy, enterography, and histologic interpretations. Further, AI image analysis is being used to develop new endoscopic scoring with more granularity and detail than is possible using conventional methods. Advancements in natural language processing are proving to reduce laborious tasks required in the care of IBD, including documentation, information searches, and chart review. Finally, large language models and chatbots that can understand language and generate human-like replies are beginning to exhibit clinical intelligence that will revolutionize how we deliver IBD care.

Summary

Today, AI is being deployed to replicate expert judgement in specific tasks where disagreement, subjectivity, and bias are common. However, the near future will herald contributions of AI doing what we cannot, including new detailed measures of IBD, enhanced analysis of images, and perhaps even fully automating care. As we speculate on future technologic capabilities that may improve how we care for IBD, this review will also consider how we will implement and fairly use AI in practice.
Literatur
1.
Ben-Israel D, et al. The impact of machine learning on patient care: A systematic review. Artif Intell Med. 2020;103:101785.PubMed
2.
Shah NH, Milstein A, PhD SCB. Making machine learning models clinically useful. JAMA J Am Med Assoc. 2019;322:1351–2.
3.
•• Gottlieb K, et al. Central Reading of Ulcerative Colitis Clinical Trial Videos Using Neural Networks. Gastroenterology. 2021;160:710-719.e2. Key study highlighting ability of AI models to match the performance of expert reviewers in endoscopic severity scoring of ulcerative colitis using the Mayo endoscopic score and UCEIS instruments.PubMed
4.
Ungaro R, Colombel JF, Lissoos T, Peyrin-Biroulet L. A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review. Am J Gastroenterol. 2019;114:874–83.PubMedPubMedCentral
5.
Turner D, et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160:1570–83.PubMed
6.
Ferrante M, et al. Validation of endoscopic activity scores in patients with Crohn’s disease based on a post hoc analysis of data from SONIC. Gastroenterology. 2013;145:978-986.e5.PubMed
7.
Xie T, et al. Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Score (MES) in guiding the need for colectomy in patients with acute severe colitis. Gastroenterol Rep (Oxf). 2018;6:38–44.PubMed
8.
Colombel J-F, et al. Quantitative measurement and visual assessment of ileal Crohn’s disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut. 2006;55:1561–7.PubMedPubMedCentral
9.
Jairath V, et al. Reliability of measuring ileo-colonic disease activity in Crohn’s disease by magnetic resonance enterography. Inflamm Bowel Dis. 2018;24:440–9.PubMed
10.
Travis SPL, et al. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology. 2013;145:987–95.PubMed
11.
Khanna R, et al. Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn’s disease. Gut. 2016;65:1119–25.PubMed
12.
13.
Carin L, Pencina MJ. On deep learning for medical image analysis. JAMA J Am Med Assoc. 2018;320:1192–3.
14.
Daperno M, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc. 2004;60:505–12.PubMed
15.
Vashist NM, et al. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis. Cochrane Database Syst Rev. 2018;1:CD011450.
16.
Ozawa T, et al. Novel computer-assisted diagnosis system for endoscopic disease activity in patients with ulcerative colitis. Gastrointest Endosc. 2019;89:416-421.e1.PubMed
17.
Stidham RW, et al. Performance of a deep learning model vs human reviewers in grading endoscopic disease severity of patients with ulcerative colitis. JAMA Netw Open. 2019;2:e193963.PubMedPubMedCentral
18.
Maeda Y, et al. Fully automated diagnostic system with artificial intelligence using endocytoscopy to identify the presence of histologic inflammation associated with ulcerative colitis (with video). Gastrointest Endosc. 2019;89:408–15.PubMed
19.
Yao H, et al. Fully automated endoscopic disease activity assessment in ulcerative colitis. Gastrointest Endosc. 2021;93:728-736.e1.PubMed
20.
Gottlieb K, et al. Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments. Gut. 2021;70:418–26.PubMed
21.
22.
Barash Y, et al. Ulcer severity grading in video capsule images of patients with Crohn’s disease: an ordinal neural network solution. Gastrointest Endosc. 2021;93:187–92.PubMed
23.
24.
•• Stidham RW, et al. Using computer vision to improve endoscopic disease quantification in therapeutic clinical trials of ulcerative colitis. Gastroenterology. 2023. https://​doi.​org/​10.​1053/​j.​gastro.​2023.​09.​049. First study to demonstrate that artificial intelligence powered analysis of endoscopy can outperform traditional standard endoscopic measures of disease activity in ulcerative colitis.CrossRefPubMed
25.
• Maeda Y, et al. Evaluation in real-time use of artificial intelligence during colonoscopy to predict relapse of ulcerative colitis: a prospective study. Gastrointest Endosc. 2022;95:747-756.e2. Demonstration of ability to use real-time endoscopic video analysis to predict clinical outcomes in UC, potentially offering an opportunity to modify care with machine intelligence assistance.PubMed
26.
Iacucci M, et al. Artificial intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis. Gastroenterology. 2023;164:1180-1188.e2.PubMed
27.
Vitali F, et al. Endocytoscopy for assessing histologic inflammation in ulcerative colitis: development and prospective validation of the ELECT (ErLangen Endocytoscopy in ColiTis) score (with videos). Gastrointest Endosc. 2023;97:100-111.e1.PubMed
28.
29.
Remedios LW, et al. Predicting Crohn’s disease severity in the colon using mixed cell nucleus density from pseudo labels. Méd Imaging 2023: Digit Comput Pathol. 2023;12471:1247116–1247116-8.
30.
Panés J, Rimola J. Is the Objective of Treatment for Crohn’s Disease Mucosal or Transmural Healing? Clin Gastroenterol Hepatol. 2018;16:1037–9.PubMed
31.
Geyl S, et al. Transmural healing as a therapeutic goal in Crohn’s disease: a systematic review. Lancet Gastroenterol Hepatol. 2021;6:659–67.PubMed
32.
Ordás I, et al. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn’s disease. Gastroenterology. 2014;146:374-82.e1.PubMed
33.
Roseira J, Ventosa AR, de Sousa HT, Brito J. The new simplified MARIA score applies beyond clinical trials: A suitable clinical practice tool for Crohn’s disease that parallels a simple endoscopic index and fecal calprotectin. United Eur Gastroenterol J. 2020;8:1208–16.
34.
Puylaert CAJ, et al. Comparison of MRI Activity Scoring Systems and Features for the Terminal Ileum in Patients With Crohn Disease. Am J Roentgenol. 2019;212:W25–31.
35.
Lamash Y, Kurugol S, Warfield SK. Semi-Automated Extraction of Crohns Disease MR Imaging Markers using a 3D Residual CNN with Distance Prior. Deep Learn Med Image Anal Multimodal Learn Clin Decis Support. 2018;2018(11045):218–26.
36.
Enchakalody BE, et al. Machine learning methods to predict presence of intestine damage in patients with Crohn’s disease. in Medical Imaging 2020: Computer-Aided Diagnosis 11314:1131436 (Medical Imaging 2020: Computer-Aided Diagnosis, 2020).
37.
Stidham RW, et al. Assessing Small Bowel Stricturing and Morphology in Crohn’s Disease Using Semi-automated Image Analysis. Inflamm Bowel Dis. 2019;11:274.
38.
Bruining DH, et al. Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn’s Disease. Gastroenterology. 2018;154:1172–94.PubMed
39.
Kucharzik T, et al. Use of Intestinal Ultrasound to Monitor Crohn’s Disease Activity. Clin Gastroenterol Hepatol. 2017;15:535-542.e2.PubMed
40.
41.
Yao J, et al. Computed tomography-based radiomics nomogram using machine learning for predicting 1-year surgical risk after diagnosis of Crohn’s disease. Méd Phys. 2023;50:3862–72.PubMed
42.
43.
• Li X, et al. Development and Validation of a Novel Computed-Tomography Enterography Radiomic Approach for Characterization of Intestinal Fibrosis in Crohn’s Disease. Gastroenterology. 2021. https://​doi.​org/​10.​1053/​j.​gastro.​2021.​02.​027. AI-powered radiomics analysis of cross sectional imaging was able to better discriminate inflammation from fibrosis in resected bowel specimens better than multiple experienced radiologists. This suggests that in specific tasks, AI may outperform clinical experts owing to ability to appreciate patterns unseen by human operators.CrossRefPubMedPubMedCentral
44.
45.
Kang T, Perotte A, Tang Y, Ta C, Weng C. UMLS-based data augmentation for natural language processing of clinical research literature. J Am Med Inform Assoc. 2021;28:812–23.PubMed
46.
Ananthakrishnan AN, et al. Improving case definition of Crohn’s disease and ulcerative colitis in electronic medical records using natural language processing: a novel informatics approach. Inflamm Bowel Dis. 2013;19:1411–20.PubMed
47.
Stidham RW, et al. Identifying the presence, activity, and status of extraintestinal manifestations of inflammatory bowel disease using natural language processing of clinical notes. Inflamm Bowel Dis. 2022;29:503–10.
48.
Kurowski JA, et al. Computable phenotype of a Crohn’s disease natural history model. Méd Decis Mak. 2022;42:937–44.
49.
50.
Lee T-C, et al. ChatGPT answers common patient questions about colonoscopy. Gastroenterology. 2023;165:509-511.e7.PubMed
51.
Mukherjee S, et al. Assessing ChatGPT’s Ability to Reply to Queries Regarding Colon Cancer Screening Based on Multisociety Guidelines. Gastro hep Adv. 2023;2:1040–3.PubMedPubMedCentral
52.
53.
•• Brin D, et al. Comparing ChatGPT and GPT-4 performance in USMLE soft skill assessments. Sci Rep. 2023;13:16492. Major scientific technical paper elaborating on GPT capibilities to convincingly reproduce expert medical knowledge on standardized testing. This manuscript outlines the methods used by transformers to understand text-knowledge and highlights the generative nature of AI answers to medical questions.PubMedPubMedCentral
54.
• Suchman K, Garg S, Trindade AJ. Chat generative pretrained transformer fails the multiple-choice American College of Gastroenterology Self-Assessment Test. Am J Gastroenterol. 2023;118:2280–2. Important manuscript highlighting that gastroenterology knowledge remains beyond the capabilities of current GPT tools. This work details poor non-passing performance of GPT on ACG self assessment questionnaire.PubMed
55.
Levartovsky A, Ben-Horin S, Kopylov U, Klang E, Barash Y. Towards AI-Augmented Clinical Decision-Making: An Examination of ChatGPT’s Utility in Acute Ulcerative Colitis Presentations. Am J Gastroenterol. 2023;118:2283–9.PubMed
56.
Metadaten
Titel
Artificial Intelligence and IBD: Where are We Now and Where Will We Be in the Future?
verfasst von
Mehwish Ahmed
Molly L. Stone
Ryan W. Stidham
Publikationsdatum
27.02.2024
Verlag
Springer US
Erschienen in
Current Gastroenterology Reports / Ausgabe 5/2024
Print ISSN: 1522-8037
Elektronische ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-024-00918-8

Weitere Artikel der Ausgabe 5/2024

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

CDK4/6-Inhibitoren bei Brustkrebs in die Zweitlinie aufschieben?

Ergebnisse einer Phase-III-Studie sprechen dafür, dass die Behandlung mit CDK4/6-Inhibitoren bei fortgeschrittenem HR-positivem, HER2-negativem Brustkrebs auch auf die Zweitlinie verschoben werden könnte, ohne die onkologischen Ergebnisse zu kompromittieren.

Inhalative Steroide bei COPD nicht kardioprotektiv

  • 10.01.2025
  • COPD
  • Nachrichten

Ob inhalative Kortikosteroide (ICS) COPD-Kranke außer vor akuten Exazerbationen auch vor kardiovaskulären Komplikationen schützen können, ist unklar. Eine bevölkerungsbasierte Studie aus England spricht nicht dafür.

Kaffeegenuss sicher bei Vorhofflimmern

Menschen mit Vorhofflimmern fürchten oft, Kaffee könnte schlecht für ihr Herz sein. Solche Ängste sind offenbar unbegründet: Zwei Schweizer Untersuchungen deuten sogar auf eine reduzierte Rate von kardiovaskulären Ereignissen unter Kaffeetrinkern.

Cannabisextrakt verbessert Antiemese bei Chemotherapie

Sprechen Krebskranke auf die übliche Antiemese während einer Chemotherapie nicht ausreichend an, lohnt sich möglicherweise eine Behandlung mit Cannabisextrakt. In einer Phase-2/3-Studie ließ sich die antiemetische Response mit einem solchen Extrakt erheblich verbessern.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Jetzt 10 CME-Punkte sammeln

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise